Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Firefly Neuroscience (AIFF) over the last 14 years, with Q3 2025 value amounting to $13.5 million.

  • Firefly Neuroscience's Shares Outstanding rose 5965.64% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 5965.64%. This contributed to the annual value of $8.1 million for FY2024, which is 12079.52% up from last year.
  • Latest data reveals that Firefly Neuroscience reported Shares Outstanding of $13.5 million as of Q3 2025, which was up 5965.64% from $13.3 million recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Shares Outstanding high stood at $13.5 million for Q3 2025, and its period low was $265485.0 during Q4 2022.
  • Its 5-year average for Shares Outstanding is $5.3 million, with a median of $3.5 million in 2023.
  • As far as peak fluctuations go, Firefly Neuroscience's Shares Outstanding plummeted by 8594.0% in 2022, and later skyrocketed by 128559.62% in 2023.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Shares Outstanding stood at $1.9 million in 2021, then plummeted by 85.94% to $265485.0 in 2022, then surged by 1285.6% to $3.7 million in 2023, then surged by 120.8% to $8.1 million in 2024, then soared by 66.62% to $13.5 million in 2025.
  • Its Shares Outstanding was $13.5 million in Q3 2025, compared to $13.3 million in Q2 2025 and $11.7 million in Q1 2025.